Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.
Parkinsonism in multiple sclerosis patients: A casual or causal association?
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
The Effect of Culture on Two Information-Processing Speed Tests.
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica.
Benefits of whole-body vibration with an oscillating platform for people with multiple sclerosis: a systematic review.
[Diffusion-tensor magnetic resonance tomography and tractography in multiple sclerosis: a review].
Assay selection affects John Cunningham virus serostatus classification in multiple sclerosis.
Sodium channel Nav1.8: Emerging links to human disease.
Natural killer cells in human autoimmune disorders.
Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans.
Is There Extra Cost of Institutional Care for MS Patients?
Treatment with interferon beta for multiple sclerosis.
The role of mast cells in neuroinflammation.
Management of pain in advanced disease.
[Coping with multiple sclerosis in partnerships : A systematic review of the literature.]
Multiple Sclerosis Alters the Mechanical Work Performed on the Body's Center of Mass during Gait.
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Body composition in multiple sclerosis.
Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
Pages
« first
‹ previous
…
287
288
289
290
291
292
293
294
295
…
next ›
last »